Progress in the Medicinal Chemistry of Group III Metabotropic Glutamate Receptors

被引：5

作者：

Liu, Kevin G. ^{[1
]}

Doller, Dario ^{[1
]}

机构：

[1] Lundbeck Res USA, Chem & Pharmacokinet Sci, Paramus, NJ 07652 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 46 | 2011年 / 46卷

关键词：

POSITIVE ALLOSTERIC MODULATORS; PHARMACOLOGICAL CHARACTERIZATION; PHENYLGLYCINE DERIVATIVES; SELECTIVE ANTAGONIST; AGONIST; POTENT; (S)-3,4-DCPG; PHCCC; ACTIVATION; DISCOVERY;

D O I：

10.1016/B978-0-12-386009-5.00026-6

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3 / 17

页数：15

共 72 条

[1]

Acher F., 2007, Patent Application, Patent No. [W02007052169, 2007052169, WO2007052169]

[2] Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: New tools to discriminate between metabotropic glutamate receptor subtypes [J].

Acher, FC ;

Tellier, FJ ;

Azerad, R ;

Brabet, IN ;

Fagni, L ;

Pin, JPR .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (19) :3119-3129

[3] (S)-Homo-AMPA, a specific agonist at the mGlu(6) subtype of metabotropic glutamic acid receptors [J].

Ahmadian, H ;

Nielsen, B ;

Brauner-Osborne, H ;

Johansen, TN ;

Stensbol, TB ;

Slok, FA ;

Sekiyama, N ;

Nakanishi, S ;

KrogsgaardLarsen, P ;

Madsen, U .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) :3700-3705

[4] A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates [J].

Annoura, H ;

Fukunaga, A ;

Uesugi, M ;

Tatsuoka, T ;

Horikawa, Y .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) :763-766

[5] FINGERPRINTING G-PROTEIN-COUPLED RECEPTORS [J].

ATTWOOD, TK ;

FINDLAY, JBC .

PROTEIN ENGINEERING, 1994, 7 (02) :195-203

[6] Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated [J].

Ayala, Jennifer E. ;

Niswender, Colleen M. ;

Luo, Qingwel ;

Banko, Jessica L. ;

Conn, P. Jeffrey .

NEUROPHARMACOLOGY, 2008, 54 (05) :804-814

[7] Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [J].

Battaglia, Giuseppe ;

Busceti, Carla L. ;

Molinaro, Gemma ;

Biagioni, Francesca ;

Traficante, Anna ;

Nicoletti, Ferdinando ;

Bruno, Valeria .

JOURNAL OF NEUROSCIENCE, 2006, 26 (27) :7222-7229

[8] Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism [J].

Beurrier, Corinne ;

Lopez, Sebastien ;

Revy, Delphine ;

Selvam, Chelliah ;

Goudet, Cyril ;

Lherondel, Morgane ;

Gubellini, Paolo ;

Kerkerian-LeGoff, Lydia ;

Acher, Francine ;

Pin, Jean-Philippe ;

Amalric, Marianne .

FASEB JOURNAL, 2009, 23 (10) :3619-3628

[9]

Bolea C., 2009, Patent, Patent No. [WO2009010455A2, 2009010455]

[10] A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid [J].

Brauner-Osborne, H ;

Slok, FA ;

Skjaerbaek, N ;

Ebert, B ;

Sekiyama, N ;

Nakanishi, S ;

KrogsgaardLarsen, P .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3188-3194

← 1 2 3 4 5 6 7 8 →